Search results
Results from the WOW.Com Content Network
In 2004, the year cinacalcet was first approved in the United States, approximately 15% of renal-transplant patients with tertiary hyperparathyroidism underwent parathyroidectomy at the university ...
Among the most common symptoms of thyrotoxicosis are anxiety, insomnia, palpitations, unintentional weight loss, diarrhea, and heat intolerance. With Graves disease, additional symptoms may ...
Cite this: Stones, Bones, Groans, and Moans: Could This Be Primary Hyperparathyroidism? - Medscape - September 16, 2024.
Hypoparathyroidism and hyperparathyroidism guidelines developed by more than 100 global experts were presented at the ASBMR meeting and will be published next year, replacing 2014 and 2016 guidelines.
A Patient With the MEN1-Associated Hyperparathyroidism, Responsive to Cinacalcet. Alberto Falchetti; Antonio Cilotti; Luca Vagelli; Laura Masi; Antonietta Amedei; Federica Cioppi; Francesco ...
Compared with the 2110 patients with PHP only, the 74 with both FM and PHP were significantly more likely to have musculoskeletal symptoms (100% vs 54%), fatigue/depression (96% vs 57%), cognitive ...
The Natural History of Primary Hyperparathyroidism with or without Parathyroid Surgery after 15 Years. J Clin Endocrinol Metab 2008 Sep 93 (9):3462-70]. 2008 Sep 15.
Miriam E. Tucker. August 12, 2024. 0. The US Food and Drug Administration (FDA) has approved palopegteriparatide (Yorvipath) for the treatment of hypoparathyroidism in adults, the drug's ...
The authors enrolled patients with moderate to severe hyperparathyroidism (PTH ≥ 500 pg/mL) who were receiving hemodialysis 3 times a week. All patients had an albumin-corrected calcium of ≥8. ...
The proportion of wounds healed at 16 weeks was higher with intact fish skin grafts than with standard-of-care (44.0% vs 26.4% adjusted odds ratio [aOR], 2.58; 95% CI, 1.48-4.56). The fish skin ...